Ixaka Ltd
PrivateCompany Overview
Ixaka Ltd is a biotechnology company that develops cell and gene therapies, including concentrated multi-cell therapies and targeted nanoparticle therapeutics, for the treatment of oncology, cardiovascular, neurological, and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
cell therapygene therapyregenerative medicineautologous therapyin vivo gene deliverytargeted nanoparticleTNPCAR-T therapychronic limb-threatening ischemiaCLTIbiotechadvanced therapy medicinal productsATMPclinical stage biotechdrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ixaka Ltd Comparables
Compare Ixaka Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioGenCell | 87% | |
| Ambulero, Inc. | 87% | |
| Hemostemix | 82% | |
Ixaka Ltd Funding Rounds
Historical fundraising activity
Ixaka Ltd Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ixaka Ltd's valuation, stock price, and market status.
See something wrong or outdated?